This compound is a Fmoc-protected D-valine derivative used as a building block in solid-phase peptide synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) group for temporary amino protection, along with a carboxylic acid for peptide bond formation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 84624-17-9
(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxybutanoic acid
pharmaceutical intermediate
Fmoc-D-allo-isoleucine
research compound
(2S,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylpentanoic acid
research reagent
Fmoc-L-alpha-Alanine
pharmaceutical intermediate
Fmoc-O-tert-butyl-L-tyrosine
pharmaceutical intermediate
Fmoc-N-Methyl-L-alanine
pharmaceutical intermediate
Fmoc-Lys(Boc)-Ser(Psi(Me,Me)pro)-OH
pharmaceutical intermediate
Cbz-Cyclohexyl-L-glycine
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid
UGNIYGNGCNXHTR-GOSISDBHSA-N
CC(C)[C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13